Nature

Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on ...

Beginning in July of 2004, we adopted fludarabine and once daily i.v. BU as our standard conditioning regimen for patients undergoing allogeneic HCT. We optimized BU dosing by PK targeting to an ...
ascopubs.org

Phase II Study of Area Under the Plasma-Concentration-Versus-Time Curve–Based Carboplatin Plus Standard-Dose Intravenous Etoposide in Elderly Patients With Small-Cell Lung Cancer

Multiple Courses of High-Dose Ifosfamide, Carboplatin, and Etoposide With Peripheral-Blood Progenitor Cells and Filgrastim for Small-Cell Lung Cancer: A Feasibility Study by the European Group for ...
The American Journal of Managed Care

Data on Adalimumab Biosimilar Confirm Equivalence of Low- and High-Concentration Formulations

Research presented at EULAR 2022 demonstrated the pharmacokinetic equivalence of a low-concentration version of the adalimumab biosimilar SB5 and a high-concentration version. While 2023 is becoming ...